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www.jacc-interventions.org to view.Efﬁcacy of Radial Versus Femoral Access in the Acute Coronary Syndrome:
Is it the Operator or the Operation That Matters?1405Michel R. Le May, Kuljit Singh, George A. WellsIn the recently published MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access
Site and Systemic Implementation of angioX) trial, the use of transradial access (TRA) compared to
transfemoral access (TFA) during percutaneous coronary intervention (PCI) for acute coronary
syndrome (ACS) was associated with a reduction in net adverse cardiovascular events. However,
the results of MATRIX must be interpreted with caution due to several limitations including the
strong modulating effect of operator/center experience on the relative efﬁcacy of TRA and the
inclusion of 2 distinct patient populations (ST-segment elevation and non-ST-segment elevation
ACS). Further research is needed before strong, evidence-based recommendations regarding the
approach of choice during PCI for ACS can be made.MINI-FOCUS: CORONARY
PHYSIOLOGYZero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary
Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive
Index for Predicting the Extent of Myocardial Infarction at 6 Months: An OxAMI Study
(Oxford Acute Myocardial Infarction)1410Niket Patel, Ricardo Petraco, Erica Dall’Armellina, George Kassimis,
Giovanni Luigi De Maria, Sam Dawkins, Regent Lee, Bernard D. Prendergast,
Robin P. Choudhury, John C. Forfar, Keith M. Channon, Justin Davies, Adrian P. Banning,
Rajesh K. KharbandaZero-ﬂow pressure (Pzf) is the calculated pressure at which coronary ﬂow would cease. In this study,
Pzf was found to be superior to index of microcirculatory resistance and hyperemic microvascular
resistance in predicting infarction size following primary percutaneous coronary intervention for ST-
segment elevation myocardial infarction. Furthermore, Pzf correlated signiﬁcantly with
transmurality of infarction, salvage index, and 6-month ejection fraction. Using a cutoff of Pzf #42
mm Hg allowed the identiﬁcation of a cohort of patients with adverse infarction-related
electrocardiographic, angiographic, and cardiac magnetic resonance features. Therefore, Pzf may
provide important prognostic information at the time of PPCI.CONTINUED ON PAGE A-33
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SEPTEMBER 2015 VOLUME 8, NUMBER 11Intracoronary Adenosine: Dose–Response Relationship With Hyperemia 1422
Julien Adjedj, Gabor G. Toth, Nils P. Johnson, Mariano Pellicano, Angela Ferrara,
Vincent Floré, Giuseppe Di Gioia, Emanuele Barbato, Olivier Muller, Bernard De BruyneThe authors sought to establish the optimal dosage of intracoronary adenosine to induce hyperemia.
Doppler ﬂow velocity measurements were obtained in 30 patients after 9 escalating adenosine doses
(4 to 500 mg). Flow velocity did not increase signiﬁcantly beyond dosages of 60 mg for the right
coronary artery (RCA) and 160 mg for left coronary artery (LCA). Transient A-V block incidence
was 40% after 100 mg in RCA and 15% after 200 mg in LCA. Thus, an intracoronary bolus injection
of 100 mg in RCA and 200 mg in LCA induces maximum coronary hyperemia without hemodynamic
changes and with minimal side effects.n EDITORIAL COMMENT
Intracoronary Adenosine for Maximal Hyperemia: Less Is More.More or Less? 1431
Jamie Layland, Colin Berry
Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in
Patients With Angina in the Absence of Obstructive Coronary Artery Disease1433Yuhei Kobayashi, William F. Fearon, Yasuhiro Honda, Shigemitsu Tanaka,
Vedant Pargaonkar, Peter J. Fitzgerald, David P. Lee, Marcia Stefanick, Alan C. Yeung,
Jennifer A. TremmelCoronary microvascular dysfunction is associated with worse long-term outcomes, especially in
women. The authors investigated sex differences in coronary physiology in 117 women and 40 men
with angina in the absence of obstructive coronary artery disease, using coronary ﬂow reserve (CFR)
and the index of microcirculatory resistance (IMR). Microvascular function by IMR was similar
between the sexes (p ¼ 0.45), whereas CFR was lower in women (3.8  1.6 vs. 4.8  1.9,
p ¼ 0.004). This was primarily due to a shorter resting mean transit time in women (p ¼ 0.005),
suggesting increased resting coronary ﬂow. Sex differences should be considered in the
interpretation of physiological indexes using resting coronary ﬂow.n EDITORIAL COMMENT
Coronary Microvascular Dysfunction: Does Sex Matter? 1442
Alexandra J. Lansky, Cody PietrasCONTINUED ON PAGE A-34
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SEPTEMBER 2015 VOLUME 8, NUMBER 11Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and
Nonobstructive Coronary Artery Disease1445Jaskanwal D. Sara, R. Jay Widmer, Yasushi Matsuzawa, Ryan J. Lennon,
Lilach O. Lerman, Amir LermanCoronary microvascular abnormalities may be related to endothelial-dependent or -independent
mechanisms and can mediate ischemia and lead to an increased risk of cardiovascular events. The
current study shows that patients with chest pain and nonobstructive coronary artery disease have
a high prevalence of coronary microvascular abnormalities irrespective of sex. These abnormalities
correlate poorly with conventional cardiovascular risk factors and are dissociated from the ﬁndings
of noninvasive functional testing. The current study supports the role of invasive coronary
pharmacological provocation testing to comprehensively assess coronary microvascular function in
patients with chest pain and nonobstructive coronary artery disease.n EDITORIAL COMMENT
Can Advanced Physiological Testing Bridge the Gap Between Chest Pain and
Nonobstructive Coronary Atherosclerosis?1454Sang-Yong Yoo, Habib SamadyCLINICAL RESEARCH
CORONARY Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment
Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary
Intervention: Results of a Prospective Randomized Pharmacokinetic
and Pharmacodynamic Investigation1457Francesco Franchi, Fabiana Rollini, Jung Rae Cho, Mona Bhatti, Christopher DeGroat,
Elisabetta Ferrante, Elizabeth C. Dunn, Amit Nanavati, Edward Carraway,
Siva Suryadevara, Martin M. Zenni, Luis A. Guzman, Theodore A. Bass,
Dominick J. AngiolilloPatients undergoing primary percutaneous coronary intervention (PPCI) frequently have suboptimal
platelet inhibition in the early hours after ticagrelor loading dose (LD). This prospective, randomized
study aimed to assess the pharmacokinetic (PK) and pharmacodynamic (PD) proﬁles of escalating
(180 mg, 270 mg, or 360 mg) ticagrelor LD regimens in patients undergoing PPCI. PK/PD analysis
were performed at 7 time points and showed that the impaired response to ticagrelor in the early
hours after drug administration cannot be overcome by increasing LD regimens. These PD ﬁndings
are largely attributed to PK abnormalities, indicating a delay in drug absorption.
SEE ADDITIONAL CONTENT ONLINECONTINUED ON PAGE A-35
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PAGE A-35Clinical and Functional Outcomes Associated With Myocardial Injury After
Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis
From the PARTNER Trial (Placement of Aortic Transcatheter Valves)1468Jean-Michel Paradis, Hersh S. Maniar, John M. Lasala, Susheel Kodali, Mathew Williams,
Brian R. Lindman, Ralph J. Damiano, Jr., Marc R. Moon, Raj R. Makkar,
Vinod H. Thourani, Vasilis Babaliaros, Ke Xu, Girma Minalu Ayele, Lars Svensson,
Martin B. Leon, Alan ZajariasThere is a paucity of data regarding the impact of myocardial damage after transcatheter aortic valve
replacement (TAVR). This study demonstrates that after transfemoral TAVR, a higher elevation of
cardiac troponin I is associated with higher rates of 30-day all-cause and cardiovascular mortality.
A greater rise of creatine kinase-myocardial band after transfemoral TAVR is correlated with
increased frequencies of 30-day and 1-year all-cause and cardiovascular mortality. The degree of
myocardial injury after transapical TAVR had no inﬂuence on clinical and echocardiographic
outcomes at 30 days and 1 year.
SEE ADDITIONAL CONTENT ONLINERepeat MitraClip Therapy for Signiﬁcant Recurrent Mitral Regurgitation in High Surgical
Risk Patients: Impact of Loss of Leaﬂet Insertion1480Felix Kreidel, Christian Frerker, Michael Schlüter, Hannes Alessandrini,
Thomas Thielsen, Stephan Geidel, Ulrich Schäfer, Karl-Heinz KuckThe authors report their experience with repeat MitraClip therapy in 21 patients (age 77  10 years;
14 men) considered inoperable or at high surgical risk. Repeat procedures at a median of 6.3 months
after the index intervention were successful (discharge mitral regurgitation #2+) in 13 patients
(62%). Procedural success was markedly more often achieved in 13 patients with adequate leaﬂet
insertion at the time of the repeat intervention (11 of 13 [85%]) than in 8 patients with loss of leaﬂet
insertion (2 of 8 [25%]), manifested by either leaﬂet tear/perforation or partial clip detachment.
Repeat MitraClip intervention appears to be viable primarily in patients with adequate leaﬂet insertion.n EDITORIAL COMMENT
Repeat MitraClip Procedures: In Search of the Perfect Grasp 1490
Jason H. Rogers, Thomas SmithCONTINUED ON PAGE A-36
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PAGE A-363-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients
With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up
Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical
Limb Ischemia1493Osamu Iida, Masato Nakamura, Yasutaka Yamauchi, Masashi Fukunaga, Yoshiaki Yokoi,
Hiroyoshi Yokoi, Yoshimistu Soga, Kan Zen, Nobuhiro Suematsu, Naoto Inoue,
Kenji Suzuki, Keisuke Hirano, Yoshiaki Shintani, Yusuke Miyashita, Kazushi Urasawa,
Ikuro Kitano, Taketsugu Tsuchiya, Kenji Kawamoto, Terutoshi Yamaoka,
Michitaka Uesugi, Toshiro Shinke, Yasuhiro Oba, Norihiko Ohura, Masaaki Uematsu,
Mitsuyoshi Takahara, Toshimitsu Hamasaki, Shinsuke Nanto,
on behalf of the OLIVE InvestigatorsThis study sought to investigate the 3-year follow-up results of OLIVE registry patients. The
completion rate of 3-year follow-up was 95%. Three-year amputation-free survival, freedom from
major adverse limb events, freedom from reintervention rate, and wound recurrence rate were
55.2%, 84.0%, 43.2%, and 43.9%, respectively. In critical limb ischemia patients with
infrainguinal lesions, the 3-year clinical results of endovascular treatment were reasonable despite
high reintervention and a moderate ulcer recurrence rate.n EDITORIAL COMMENT
Intermediate-Term Results of the OLIVE Registry 1503
Matthew T. Menard
Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Internal Carotid
Artery Stent Implantation1506Michael Donahue, Gabriella Visconti, Amelia Focaccio, Lucio Selvetella,
Maria Baldassarre, Chiara Viviani Anselmi, Carlo BriguoriAcute kidney injury (AKI) following carotid artery stenting may occur because of iodinated contrast
media and hemodynamic depression. AKI occurred in 26 of 126 patients (21%) with chronic kidney
disease who underwent carotid artery stenting. Hemodynamic depression occurred in 17 of 26
patients (65.5%) in the AKI group versus 35 of 100 patients (35%) in the non-AKI group (p ¼
0.005). Independent predictors of AKI were hemodynamic depression, risk score, and male sex,
but not contrast media volume. Independent predictors of 30-day major adverse events at 30 days
were AKI and hemodynamic depression.n EDITORIAL COMMENT
Acute Kidney Injury After Carotid Artery Stenting 1515
Peter A. McCullough, Allan Young, William P. ShutzeCONTINUED ON PAGE A-37
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INTERVENTIONHybrid Strategy for Long Diffuse Coronary Lesion 1518
Sandeep Basavarajaiah, Mamoon Qadir
Transapical Mitral Valve Implantation for the Treatment of Severe Native Mitral Valve
Stenosis in a Prohibitive Surgical Risk Patient: Importance of Comprehensive Cardiac
Computed Tomography Procedural Planning1522Guilherme F. Attizzani, Anas Fares, Chor Cheung Tam, Bimal Padaliya, Stacey Mazzurco,
Kehllee L. Popovich, Angela C. Davis, Elizabeth Staunton, Hiram G. Bezerra,
Alan Markowitz, Daniel I. Simon, Marco A. Costa, Basar Sareyyupoglu
n ONLINE FEATURE Chest Pain Post-Aortic Valve Surgery: Is It Serious? e173
Sandeep Basavarajaiah, Anik Appaji
n ONLINE FEATURE Multidetector Row Computed Tomography for Percutaneous
Closure of a Left Ventricular Free Wall Rupture After Myocardial Infarctione175I-Chen Tsai, Ming-Chih Lin, Sheng-Ling Jan, Yun-Ching Fu
n ONLINE FEATURE From Radial Artery to Embolus: A Rare Complication of
Transradial Angiographye177Catherine Jaworski, Adam J. Brown, Stephen P. Hoole, Martin Goddard, Nick E.J. West
n ONLINE FEATURE Emergency Percutaneous Closure of an Iatrogenic Atrial Septal
Defect Causing Right-to-Left Shunt and Severe Refractory Hypoxemia After Pulmonary
Vein Isolatione179Konstantinos Aznaouridis, Neil Hobson, Christopher Rigg, Thanjavur Bragadeesh
n ONLINE FEATURE The Impassable Septum: Direct Left Atrial MitraClip Delivery via
a Novel Port Access Approache183Rakesh M. Suri, Joseph F. Malouf, Vuyisile T. Nkomo, Erica D. Wittwer, Richard C. Daly,
Charanjit S. Rihal
n ONLINE FEATURE Imaging Comparison of a Bioresorbable Vascular Scaffold by
High-Frequency Intravascular Ultrasound and Optical Coherence Tomographye187Peiren Shan, Apurva Motivala, Jeffrey Moses, Akiko Maehara, Gary S. Mintz, Ziad A. Ali
n ONLINE FEATURE Venous Strangulation as an Unusual Cause of MitraClip System
Delivery Failuree189Mohammed A. Al-Hijji, Mackram F. Eleid, Haraldur Bjarnason, Thomas A. Foley,
Guy S. Reeder, Charanjit S. Rihal
n ONLINE FEATURE Severe Renal Artery Stenosis After Renal Sympathetic
Denervatione193Alejandro Diego-Nieto, Ignacio Cruz-Gonzalez, Javier Martin-Moreiras,
Juan C. Rama-Merchan, Javier Rodriguez-Collado, Pedro L. Sanchez-Fernandez
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Spencer B. King III
